- Five Kilometers, 3.11 Miles, and $230,000 for Cancer Science: Running for Research at the AACR Annual Meeting
- A Graduate Student’s Roadmap to Making the Most of AACR Membership
- How Does the Most Important Cancer Research Meeting in the World Come Together?
- AACR Associate Members Receive Warm Reception at Early-career Hill Day
- FDA Approvals in Oncology: January-March 2026
- Cancer Today’s Spring 2026 Issue: Using AI Chatbots to Help Inform Care Decisions, When to Monitor a Slow-growing Cancer, and More
- Editors’ Picks, March 2026: Pediatric Leukemia Development, Low-dose Tamoxifen Use, and More
- AACR on Campus Taiwan: Providing a New Perspective on Cancer Research
- Bloodlines Series: What Is Smoldering Myeloma?
- Capturing China’s Growing Scientific Momentum in AACR Journals
- Highlights From AACR IO 2026: Breaching the Tumor Microenvironment Fortress With New CAR T and Chimeras
- Cancer Risk Estimates: What Do Those Numbers Mean?
- AACR IO 2026 Keynote Highlights: The Tale of Tregs Told by Nobel Laureate Fred Ramsdell
- Editors’ Picks, February 2026: FDA’s Accelerated Approval Pathway, Overcoming Resistance to KRAS Inhibition, and More
- AACR IO 2026 Keynote Highlights: Cancer Vaccines Are Here, and Upgrading T Cells To Thrive in the Tumor Microenvironment
